QTI QT IMAGING HOLDINGS, INC.
Electromedical & Electrotherapeutic Apparatus · Nasdaq · SEC CIK 1844505 · Fiscal year ends 12/31
Financial factors as of 2026-06-30 (2026Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY220.0%
TTM net income YoY8.2%
TTM EPS YoY58.5%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin40.4%
Operating margin-24.8%
Net margin-77.3%
FCF margin-48.2%
EBITDA margin-24.5%
Returns
ROE-2,125.0%
ROA-96.6%
ROIC (approx.)-98.7%
Asset turnover1.25x
Leverage & solvency
Liabilities / assets92.7%
Debt / equity5.07x
Current ratio3.10x
Interest coverage—
Cash quality & payout
Operating cash flow / net income0.61x
Accruals ratio-37.6%
Payout ratio—
Capex / revenue1.0%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $7.34M | $7.43M | $6.53M | $8.28M | $4.19M | $3.66M | $2.80M | $846,497 |
| Cost of revenue | $4.31M | $4.38M | $3.86M | $5.13M | $2.39M | $1.83M | $986,000 | $446,586 |
| Gross profit | $3.03M | $3.06M | $2.67M | $3.14M | $1.80M | $1.83M | $1.81M | $399,911 |
| R&D expense | $1.72M | $1.62M | $1.72M | $1.24M | $939,000 | $901,000 | $852,000 | $774,498 |
| SG&A expense | $3.75M | $3.30M | $3.30M | $2.60M | $2.52M | $1.97M | $2.00M | $1.68M |
| Operating income | -$2.45M | -$1.86M | -$2.35M | -$700,211 | -$1.65M | -$1.04M | -$1.04M | -$2.05M |
| Pretax income | -$297,000 | -$11.07M | — | -$1.39M | -$4.56M | -$4.00M | — | -$3.50M |
| Income tax | $0 | $2,000 | — | -$3,782 | $0 | $3,000 | — | -$15,783 |
| Net income | -$297,000 | -$11.07M | -$3.41M | -$1.39M | -$4.56M | -$4.00M | -$11.14M | -$3.49M |
| EBITDA | -$2.39M | -$1.84M | -$2.33M | -$684,211 | -$1.61M | -$1.00M | -$1.00M | -$2.02M |
| EPS (basic) | -0.02 | -0.75 | -0.25 | — | -0.47 | -0.42 | -1.21 | — |
| EPS (diluted) | -0.02 | -0.75 | -0.25 | — | -0.47 | -0.42 | -1.21 | — |
| Weighted avg. shares (diluted) | 15.89M | 14.83M | 13.80M | — | 9.60M | 9.45M | 9.17M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $8.12M | $10.92M | $6.90M | $10.41M | $1.72M | $2.02M | $3.01M | $1.17M |
| Receivables | $7.34M | $7.40M | $6.35M | $5.78M | $3.24M | $3.65M | $2.78M | $67,000 |
| Inventory | $11.48M | $9.87M | $6.83M | $5.03M | $5.24M | $3.23M | $2.87M | $3.14M |
| Current assets | $28.20M | $29.42M | $21.20M | $22.09M | $11.29M | $10.67M | $9.81M | $4.92M |
| PP&E, net | $889,000 | $793,000 | $315,000 | $318,000 | $127,127 | $166,676 | $163,759 | $196,000 |
| Total assets | $30.52M | $30.63M | $22.03M | $23.02M | $12.12M | $11.63M | $10.86M | $6.09M |
| Current liabilities | $10.16M | $9.50M | $8.53M | $7.87M | $12.74M | $6.31M | $5.28M | $9.79M |
| Long-term debt | $11.40M | $11.40M | $10.10M | $10.11M | $15.12M | $10.14M | $10.16M | $9.93M |
| Total debt | $11.40M | $11.40M | $10.10M | $10.11M | $15.12M | $10.14M | $10.16M | $9.93M |
| Total liabilities | $27.87M | $28.38M | $18.23M | $16.58M | $21.20M | $11.96M | $31.07M | $15.62M |
| Shareholders' equity | $2.65M | $2.25M | $3.80M | $6.45M | -$9.07M | -$324,000 | -$20.21M | -$9.54M |
| Net debt | $3.27M | $473,000 | $3.20M | -$303,000 | $13.41M | $8.11M | $7.16M | $8.76M |
| Shares outstanding | 14.67M | 13.77M | 12.04M | 11.90M | 9.67M | 28.64M | 27.65M | 8.93M |
| Cash flow statement | ||||||||
| Operating cash flow | -$2.19M | -$4.84M | -$3.65M | -$3.10M | -$879,000 | -$1.44M | -$3.54M | -$1.23M |
| Capital expenditure | $72,000 | $174,000 | $17,000 | $77,182 | $0 | $46,818 | $0 | $53,200 |
| Free cash flow | -$2.26M | -$5.01M | -$3.67M | -$3.18M | -$879,000 | -$1.49M | -$3.54M | -$1.28M |
| Investing cash flow | -$72,000 | -$174,000 | -$17,000 | -$77,182 | $0 | -$46,818 | $0 | -$53,200 |
| Financing cash flow | -$291,000 | $9.04M | $159,000 | $11.91M | $572,000 | $524,000 | $5.35M | $908,210 |
| Depreciation & amortization | $55,000 | $21,000 | $20,000 | $16,000 | $40,000 | $38,000 | $38,000 | $26,717 |
| Stock-based compensation | $731,000 | $668,000 | $381,000 | $282,279 | $199,000 | $219,000 | $101,000 | $123,608 |
Free plan shows the latest 8 periods; Pro shows all 22 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.